evidence table

Peppermint Functional Dyspepsia Randomized Trial Evidence Table

Structured evidence table for Peppermint Functional Dyspepsia Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Peppermint Functional Dyspepsia Randomized TrialOf the more than 70,000 people included in the survey, 40% showed clear evidence of FGID, according to the Rome IV criteria [].2Storr M. (2026)S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
Peppermint Functional Dyspepsia Randomized Trial2 3 4 5 6 7 via Various risk factors for the occurrence of FD have been identified to date: Incidence of FD is increased in the female population [,].2Storr M. (2026)S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
Peppermint Functional Dyspepsia Randomized TrialHowever, the use of nonsteroidal anti‐inflammatory drugs also represents a risk factor for the development of FD.2Storr M. (2026)S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
Peppermint Functional Dyspepsia Randomized Trial1 2 3 The term “functional dyspepsia” (FD) refers to recurring or chronic symptoms of the upper abdomen that cannot be attributed to an organic disease by using standard diagnostic procedures [].2Storr M. (2026)S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
Peppermint Functional Dyspepsia Randomized TrialResults During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile.2Linas I (2025)Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
Peppermint Functional Dyspepsia Randomized TrialIntroduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms.2Linas I (2025)Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
Peppermint Functional Dyspepsia Randomized TrialMethods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed.2Linas I (2025)Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
topicPeppermint Functional Dyspepsia Randomized Trial
claimOf the more than 70,000 people included in the survey, 40% showed clear evidence of FGID, according to the Rome IV criteria [].
evidence level2
citationStorr M. (2026)
sourceS1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
topicPeppermint Functional Dyspepsia Randomized Trial
claim2 3 4 5 6 7 via Various risk factors for the occurrence of FD have been identified to date: Incidence of FD is increased in the female population [,].
evidence level2
citationStorr M. (2026)
sourceS1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
topicPeppermint Functional Dyspepsia Randomized Trial
claimHowever, the use of nonsteroidal anti‐inflammatory drugs also represents a risk factor for the development of FD.
evidence level2
citationStorr M. (2026)
sourceS1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
topicPeppermint Functional Dyspepsia Randomized Trial
claim1 2 3 The term “functional dyspepsia” (FD) refers to recurring or chronic symptoms of the upper abdomen that cannot be attributed to an organic disease by using standard diagnostic procedures [].
evidence level2
citationStorr M. (2026)
sourceS1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
topicPeppermint Functional Dyspepsia Randomized Trial
claimResults During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile.
evidence level2
citationLinas I (2025)
sourceTreatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
topicPeppermint Functional Dyspepsia Randomized Trial
claimIntroduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms.
evidence level2
citationLinas I (2025)
sourceTreatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
topicPeppermint Functional Dyspepsia Randomized Trial
claimMethods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed.
evidence level2
citationLinas I (2025)
sourceTreatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.

Learn next

Related evidence and supplement guides

GuidePeppermint Oil Dyspepsia Randomized Trial: What the Evidence SaysPeppermint Oil Dyspepsia Randomized Trial has 2 source documents in the current Migaku evidence...GuidePeppermint Irritable Bowel Syndrome Randomized Trial: What the Evidence SaysPeppermint Irritable Bowel Syndrome Randomized Trial has 2 source documents in the current Migak...GuidePeppermint Gut Health Randomized Trial: What the Evidence SaysPeppermint Gut Health Randomized Trial has 2 source documents in the current Migaku evidence dat...GuidePeppermint Oil Bloating Randomized Trial: What the Evidence SaysPeppermint Oil Bloating Randomized Trial has 2 source documents in the current Migaku evidence d...AnswerDoes Peppermint Irritable Bowel Syndrome Randomized Trial work?Peppermint Irritable Bowel Syndrome Randomized Trial has evidence relevant to strength of eviden...AnswerIs Peppermint Irritable Bowel Syndrome Randomized Trial safe?Peppermint Irritable Bowel Syndrome Randomized Trial has evidence relevant to safety, limits, an...AnswerWhat does the evidence say about Peppermint Irritable Bowel Syndrome Randomized Trial?Peppermint Irritable Bowel Syndrome Randomized Trial has evidence relevant to benefits, uncertai...AnswerDoes Curcumin Joint Stiffness Randomized Trial work?Curcumin Joint Stiffness Randomized Trial has evidence relevant to strength of evidence and what...

Source documents

  1. S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut–Brain Interaction (DGBI) [English Language Edition]
  2. Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.